[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Article Types

Countries / Regions

Search Results (7)

Search Parameters:
Journal = Reports
Section = Oncology

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
8 pages, 4947 KiB  
Case Report
Subcapital Femoral Neck Fracture in a Professionally Active Patient Undergoing Palliative Treatment for Endothelial Cell-Derived Epithelioid Haemangioendothelioma (EHE)
by Paulina Kluszczyk, Aleksandra Tobiasz, Dawid Szumilas, Mateusz Winder, Jacek Pająk, Robert Kwiatkowski and Jerzy Chudek
Reports 2024, 7(4), 111; https://doi.org/10.3390/reports7040111 - 9 Dec 2024
Viewed by 474
Abstract
Background and Clinical Significance: Femoral neck fracture frequently occurs in the elderly population but may also present in patients diagnosed with primary cancer or bone metastases. A pathological, oligosymptomatic fracture associated with epithelioid haemangioendothelioma (EHE), a rare endothelial cell-derived sarcoma, is uncommon. Case [...] Read more.
Background and Clinical Significance: Femoral neck fracture frequently occurs in the elderly population but may also present in patients diagnosed with primary cancer or bone metastases. A pathological, oligosymptomatic fracture associated with epithelioid haemangioendothelioma (EHE), a rare endothelial cell-derived sarcoma, is uncommon. Case Presentation: A 44-year-old patient underwent biopsy procedures three times (2010, 2012, 2013) for a focal lesion of the left ischium, none confirming its malignant nature. The last biopsy revealed a neoplastic tissue with features of discrete dysplasia. The lesion did not undergo medical follow-up for seven consecutive years. In August 2020, the patient presented with right lower limb pain. A CT scan, PET/CT scan, and biopsy confirmed EHE with spindle/sarcomatous features. In November 2020, chemotherapy (5xADIC) started (PET/CT confirmed a partial response). After its completion in July 2021, bone progression occurred and sirolimus-based therapy was started. After 3 months, a small liver metastasis was visualized on PET/CT, which did not result in the termination of treatment. In December 2021, pamidronate-based antiresorptive therapy was started. Liver metastasis remained stable in follow-up CT scans. Due to pelvic and spinal lesions, the patient was assisted by elbow crutches and underwent radiotherapy, remaining professionally active. The patient did not report any trauma, but in August 2023, a subsequent CT scan revealed a subcapital fracture of the left femoral neck in the fusion phase. Due to pelvic changes and the stable nature of the fracture, surgical treatment was abandoned. Conclusions: An oligosymptomatic femoral neck fracture, not requiring medical intervention is considered a rare complication of bone cancer. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>CT scan from 2009 (<b>A</b>) showing a well-demarcated osteolytic lesion in the left ischium (red arrow). The mean density of the tumour in the pre-contrast scan was 87 Hounsfield units (HU) and showed moderate enhancement in the subsequent phases reaching 112 HU in the venous phase. PET-CT from 2009 (<b>B</b>) with increased radiotracer uptake at the tumour location (red arrow).</p>
Full article ">Figure 2
<p>Haematoxylin and eosin (HE) staining (magnification is shown for each picture). (<b>A</b>) Intertrabecular space (a bone trabeculae visible in the lower left corner) filled with malignant mesenchymal neoplastic cells with myxomatous lining. Epithelioid, polymorphic tumour cells. (<b>B</b>) Epithelioid and spindle-shaped tumour cells. (<b>C</b>) Cluster of epithelioid cells. (<b>D</b>) Spindle-shaped tumour cells with intracytoplasmic inclusions. (<b>E</b>) Tumour cells with intracytoplasmic inclusions. (<b>F</b>) Cluster of tumour cells. Erythrocytes are visible in the cytoplasm of one tumour cell (central part of the photo). (<b>G</b>) Cluster of tumour cells. In a single cell, intranuclear inclusion and an eosinophil are visible. (<b>H</b>) Cluster of tumour cells. A lymphocyte visible in the cytoplasm of a single cell. (<b>I</b>) The interbone space filled with malignant mesenchymal neoplasm with myxomatous lining. Polymorphic epithelioid tumour cells.</p>
Full article ">Figure 3
<p>CT scans from September 2022 (<b>A</b>), January 2023 (<b>B</b>), and April 2023 showing decreased bone density in the left femur and pathological lesions in the vertebrae and left pelvic bones. Early signs of a subcapital fracture of the left femoral neck (red arrow) first seen in the CT from April 2023 (<b>C</b>).</p>
Full article ">Figure 4
<p>CT scan from August 2023 (<b>A</b>) showing extensive lytic infiltration of the left ischium at the initial tumour site (red arrow). Coronal plane maximum intensity projection (MIP) of the same CT (<b>B</b>). Impacted fracture of the left femoral neck (blue arrowhead) caused by the neoplastic infiltration. Pathological lesions in the left ischium and hip bone as well as in ribs 10 and 11 on the right side.</p>
Full article ">
7 pages, 3347 KiB  
Case Report
Arterial Embolization with n-Butyl-Cyanoacrylate for a Large Gluteal Intramuscular Hemangioma: A Case Report
by Nicolas Papalexis, Michela Carta, Giuliano Peta, Simone Quarchioni, Maddalena Di Carlo, Marco Miceli and Giancarlo Facchini
Reports 2024, 7(4), 106; https://doi.org/10.3390/reports7040106 - 26 Nov 2024
Viewed by 416
Abstract
Background and Clinical Significance: We wished to review the use of arterial embolization with n-butyl-cyanoacrylate (NBCA) to treat large high-flow vascular malformations due to its rapid polymerization and ability to permanently occlude large and small vessels. Case Presentation: A 52-year-old male [...] Read more.
Background and Clinical Significance: We wished to review the use of arterial embolization with n-butyl-cyanoacrylate (NBCA) to treat large high-flow vascular malformations due to its rapid polymerization and ability to permanently occlude large and small vessels. Case Presentation: A 52-year-old male presented with a two-year history of progressively worsening pain and swelling in the right gluteal area. Imaging techniques (color Doppler ultrasonography, CT, DSA, and MRI) were utilized for the diagnosis of a large high-flow intramuscular hemangioma. The mass displaced the surrounding tissues but showed no signs of lymphadenopathy or distant metastasis. The treatment involved targeting different arterial feeders over several sessions. Each procedure used NBCA–Lipiodol under fluoroscopic guidance, progressively reducing the malformation’s size and alleviating his symptoms. After the final embolization, the patient showed significant pain relief and a reduction in the size of the malformation, confirmed by follow-up imaging, demonstrating NBCA embolization’s effectiveness. The protocol’s safety and efficacy in this context are discussed. Conclusions: Arterial embolization with NBCA is a promising treatment for large high-flow vascular malformations, providing symptom relief and reductions in lesion size. While this case report highlights the procedure’s efficacy, further research is needed for a broader understanding of its long-term outcomes and potential complications. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Contrast-enhanced CT (axial) in the late arterial phase, demonstrating a large mass in the gluteal region, with many enlarged and tortuous feeding arterial vessels (asterisk), with a very tortuous and enlarged superior gluteal artery (arrow), and (<b>B</b>) the coronal view highlighting the cranio-caudal extension of the malformation and demonstrating enlarged arteries within the malformation (asterisk) and the enlarged internal iliac artery (arrow). (<b>C</b>) DSA performed with a 5 F Cobra catheter (asterisk) from the internal iliac artery demonstrating extremely enlarged superior and inferior gluteal arteries. (<b>D</b>) Pre-treatment MRI in an axial T2 non-saturated sequence showing the large lesion.</p>
Full article ">Figure 2
<p>(<b>A</b>) Contrast-enhanced CT (axial) in the late arterial phase performed 6 months after the fourth (and last) embolization. The mass is considerably reduced in diameter, with some small arterial feeders, and thrombosis of the superior gluteal artery (arrow). (<b>B</b>) Coronal view demonstrating a great reduction in pathologic vascularization with a significant reduction in the caliber of the internal iliac artery (arrow). (<b>C</b>) DSA performed at the end of the fourth embolization procedure, with the tip of the catheter (Cobra 5 F) in the internal iliac artery (asterisk) demonstrating a great reduction in vascularization and a complete stop in the arterial flow in the superior gluteal artery. (<b>D</b>) Twelve-month follow-up MRI after the last embolization showing an axial T2 non-saturated sequence.</p>
Full article ">
10 pages, 2432 KiB  
Case Report
Multinodular Vacuolating Neuronal Tumors: Symptomatic Presentation Versus Incidental Finding: Case Series and Literature Review
by Arturs Balodis, Sintija Strautmane, Paula Mežvinska and Sergejs Pavlovičs
Reports 2024, 7(4), 86; https://doi.org/10.3390/reports7040086 - 23 Oct 2024
Viewed by 759
Abstract
Background: Multinodular Vacuolating Neuronal Tumors (MVNTs) are mixed glial–neuronal brain lesions classified as World Health Organization (WHO) CNS grade 1 tumors, often associated with long-term epilepsy. First described by Huse et al. in 2013 and included in the WHO CNS classification in 2016, [...] Read more.
Background: Multinodular Vacuolating Neuronal Tumors (MVNTs) are mixed glial–neuronal brain lesions classified as World Health Organization (WHO) CNS grade 1 tumors, often associated with long-term epilepsy. First described by Huse et al. in 2013 and included in the WHO CNS classification in 2016, MVNTs present a range of clinical manifestations, from symptomatic to asymptomatic. They typically affect young to middle-aged adults and exhibit diverse presentations. Radiologically, MVNTs are usually supratentorial, frequently located in the temporal lobe but also observed in the frontal and parietal lobes. MRI is essential for diagnosis, revealing multiple coalescing subcortical or cortical nodules with hyperintense signals on T2-weighted/FLAIR sequences, often without peripheral edema or mass effects. Case Reports: This paper presents two cases: one symptomatic MVNT with significant clinical manifestations, and the other documenting an incidental finding of MVNT in an asymptomatic patient. One case shows typical temporal lobe localization, while the other highlights a rare frontal lobe localization, with clear radiological findings on T2/FLAIR sequences. Conclusions: These cases illustrate the varied clinical presentations of MVNTs and emphasize MRI’s critical role in diagnosis and management. Asymptomatic cases often require conservative management, stressing the avoidance of unnecessary invasive procedures and the importance of regular monitoring. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>,<b>B</b>) In the T2-weighted axial images, there are hyperintense vacuolating round nodules predominantly located in the subcortical region of the right frontal lobe. These nodules, which resemble “bubbles”, appear to slightly extend into the cortical area (orange arrow). When correlated with findings from other MRI sequences, these features are highly suggestive of Multinodular and Vacuolating Neuronal Tumors (MVNT).</p>
Full article ">Figure 2
<p>The FLAIR sequence in the sagittal plane (<b>A</b>,<b>B</b>) shows hyperintense, vacuolating, round nodules predominantly localized subcortically, with some likely involving the cortex as well (orange arrow).</p>
Full article ">Figure 3
<p>MRI DWI (<b>A</b>) and ADC maps (<b>B</b>), as well as T1 images after Gadovist contrast administration (<b>C</b>) and MRI perfusion images (<b>D</b>), are visible. In these MRI series, no diffusion restriction is seen, there is no decrease in ADC values, and no contrast enhancement is observed (orange arrow). The CBV in perfusion is low, indicating no signs of potential malignancy.</p>
Full article ">Figure 4
<p>(<b>A</b>,<b>B</b>) In the T2 axial images, predominantly subcortical in the anterior parts of the superior and middle gyri of the left temporal lobe, hyperintense vacuolating round nodules resembling ‘bubbles’ are seen (orange arrow). Considering the changes in other MRI series, the finding is more likely characteristic of Multinodular and Vacuolating Neuronal Tumors (MVNT).</p>
Full article ">Figure 5
<p>The MRI DWI (<b>B</b>) and ADC map (<b>A</b>) show no diffusion restriction, and the ADC map value is high (orange arrow).</p>
Full article ">Figure 6
<p>The FLAIR sequence in the axial (<b>A</b>), sagittal (<b>B</b>), and coronal (<b>C</b>) planes shows hyperintense vacuolating round nodules, predominantly localized subcortically, but also likely slightly cortically in the left temporal lobe (orange arrow). T1 after contrast in the axial plane (<b>D</b>) shows no enhancement in the visible nodular areas of the left temporal lobe.</p>
Full article ">
10 pages, 3671 KiB  
Case Report
Long-Term Survival of Patients with Adult T-Cell Leukemia/Lymphoma Treated with Amplified Natural Killer Cell Therapy
by Yuji Okubo, Sho Nagai, Yuta Katayama, Kunihiro Kitamura, Kazuhisa Hiwaki and Keisuke Teshigawara
Reports 2024, 7(3), 80; https://doi.org/10.3390/reports7030080 - 19 Sep 2024
Viewed by 1411
Abstract
Background: Adult T-cell leukemia/lymphoma (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) after a long latent infection. HTLV-1 induces the indolent or aggressive type of leukemia in 5% of HTLV-1 carriers. ATL, especially the aggressive type, is resistant to multi-agent [...] Read more.
Background: Adult T-cell leukemia/lymphoma (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) after a long latent infection. HTLV-1 induces the indolent or aggressive type of leukemia in 5% of HTLV-1 carriers. ATL, especially the aggressive type, is resistant to multi-agent chemotherapy. The indolent type often progresses to the aggressive type. Even in the most indolent-type cases, that is, smoldering ATL, the average survival time is 55.0 months. Case Presentation: Five patients with ATL were followed up for their clinical course after amplified natural killer cell (ANK) therapy. Four patients who received ANK therapy as first-line therapy achieved complete remission and showed long-term survival without aggressive conversion or relapse for more than 5 years. One patient was treated with multiagent chemotherapy due to acute exacerbation but relapsed 2 months later. She was subsequently treated with radiation and ANK therapy and survived for more than 6 years. Furthermore, ANK therapy enhanced the immune function of ATL patients to a level higher than that of normal individuals. Conclusions: ANK therapy has great potential as first-line treatment for ATL. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>ANK therapy and overall survival. Light blue bars: time from clinical diagnosis to initiation of ANK therapy. Yellow bars: time from initiation of ANK therapy to death or last follow-up day (September 2020). Red bars: duration of ANK therapy. Small numbers: number of intravenous injections of ANK cells.</p>
Full article ">Figure 2
<p>Fluctuation of serum sIL-2R levels in Patient 2 (blue broken line). Serum levels of sIL-2R before ANK therapy. Patient 2 developed acute exacerbation and was treated with multi-agent chemotherapy. She had CR, and her serum sIL-2R levels decreased to 1018 U/mL. However, her ATL relapsed two months later.</p>
Full article ">Figure 3
<p>Fluctuation of serum sIL-2R levels in Patient 1 with ANK therapy after acute exacerbation of smoldering ATL. Reprinted/adapted with permission from Ref. [<a href="#B13-reports-07-00080" class="html-bibr">13</a>]. Copyright 2018, copyright Dr. Keisuke Teshigawara.</p>
Full article ">Figure 4
<p>The level of serum sIL-2R in patients receiving ANK therapy as first-line treatment. Serum sIL-2R levels in the patients who received ANK therapy as first-line treatment and their status of watchful waiting.</p>
Full article ">Figure 5
<p>Changes in serum sIL-2R levels in patient 2. Two months after the introduction of ANK therapy, ATL recurred and skin tumors appeared frequently. Radiotherapy was administered until the seventh course of ANK therapy, but then ANK therapy alone was administered for the next 9 months, and serum sIL-2R levels decreased.</p>
Full article ">Figure 6
<p>The effect of conventional and ANK therapies on the clinical course of Patient 2. Healing of multiple skin tumor and reduction in serum sIL-2R in Patient 2. Patient 2 relapsed and showed multiple skin tumors on her left forearm (Photo 1). These skin tumors were almost cured seven months after ANK therapy (Photo 2). Thereafter, the healthy status of the left forearm continued for five years (Photo 3).</p>
Full article ">Figure 7
<p>Comparison of NK cell activity between patents achieved complete remission and healthy controls (<span class="html-italic">n</span> = 20). Yellow line: Patient 4, red line: Patient 5.</p>
Full article ">
9 pages, 574 KiB  
Article
Prevalence of Cardiotoxicity Secondary to Trastuzumab in Patients with HER-2-Positive Breast Cancer in Southeast Mexico
by Luz I. Pascual-Mathey, Midory I. Velez-Figueroa, Joel J. Díaz-Vallejo, Gustavo Mendez-Hirata and Gustavo F. Mendez-Machado
Reports 2024, 7(3), 76; https://doi.org/10.3390/reports7030076 - 14 Sep 2024
Cited by 1 | Viewed by 694
Abstract
In Mexico, breast cancer (BC) is the principal cause of death in women over 30 years old, with an annual mortality rate of 14.61 deaths per a 100,000 population. Chemotherapy, in combination with trastuzumab (TTZ), improves the survival of cancer patients; however, cardiotoxicity [...] Read more.
In Mexico, breast cancer (BC) is the principal cause of death in women over 30 years old, with an annual mortality rate of 14.61 deaths per a 100,000 population. Chemotherapy, in combination with trastuzumab (TTZ), improves the survival of cancer patients; however, cardiotoxicity (CT) is the principal consequence. CT prevalence occurs between 10% and 30% of patients; however, there are no data about the prevalence of CT in the Mexican population. This study aims to establish the prevalence of CT in patients treated with anti-HER-2 therapy among BC women in southeast Mexico. A retrospective cross-sectional study was carried out from January 2015 to July 2019. The records of 46 patients diagnosed with HER-2-positive BC who attended the Mexican Social Security Institute in the Ambulatory Care Medicine Unit were analyzed. The diagnostic criterion for CT was a decrease in LVEF > 10% from baseline or a final LVEF < 53%. CT prevalence was observed in 19 (41.3%) of women with cancer, with an average decrease in LVEF of 13%. In the population, we found an association between weight, surface area, and the loading dose of TTZ with CT. Nutritional follow-up and the administration of cardioprotective drugs are necessary to recover LVEF and avoid cardiovascular failure in women with BC and survivors. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>The flow diagram of the retrospective cross-sectional study performed is shown. After selection, thirty records were excluded; records of forty-six HER-positive BC patients were included in this study.</p>
Full article ">
7 pages, 3171 KiB  
Case Report
Myxolipoma of the Popliteal Fossa: A Rare Tumor Case Report
by Yuchen You, Jessica Cao, Brandon Nguyen, Melanie Gero and Karim Jreije
Reports 2024, 7(3), 58; https://doi.org/10.3390/reports7030058 - 25 Jul 2024
Viewed by 1244
Abstract
Myxolipomas are rare variants of lipomas characterized by abundant myxoid changes resulting from an abundant mucoid component. While myxolipomas have been reported in various anatomical locations, their occurrence in the popliteal fossa is exceptionally rare, with the last published case dating back to [...] Read more.
Myxolipomas are rare variants of lipomas characterized by abundant myxoid changes resulting from an abundant mucoid component. While myxolipomas have been reported in various anatomical locations, their occurrence in the popliteal fossa is exceptionally rare, with the last published case dating back to 1914. We present a case of a 64-year-old male with a large myxolipoma in the popliteal region. The patient underwent successful surgical excision, and a histopathological examination confirmed the diagnosis of myxolipoma. This case report highlights the clinical features, differential diagnosis, and diagnostic challenges associated with myxolipomas in the popliteal fossa. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>MRI coronal, transverse, and sagittal view of right popliteal fossa mass.</p>
Full article ">Figure 2
<p>Macroscopic appearance of excised mass.</p>
Full article ">Figure 3
<p>Isolated view of excised mass exhibiting a lobulated, soft, whitish-yellow appearance.</p>
Full article ">Figure 4
<p>Microscopic views of the mass shows no signs of cellular atypia, lipoblasts, chicken wire capillary networks, or necrosis.</p>
Full article ">
10 pages, 5256 KiB  
Case Report
Primary Melanoma of the Pineal Gland Case Report and Review of the Literature
by Daniel Rotariu, Bogdan F. Iliescu, Gabriela Dumitrescu, Antonia Nita and Bogdan Costachescu
Reports 2024, 7(2), 49; https://doi.org/10.3390/reports7020049 - 20 Jun 2024
Viewed by 937
Abstract
Pineal-region tumors are a histologically heterogeneous group of tumors and represent a rare occurrence, accounting for less than 1% of all adult intracranial tumors. Among these, primary pineal malignant melanomas (PPM) represent an even rarer entity, with only twenty-five cases being reported in [...] Read more.
Pineal-region tumors are a histologically heterogeneous group of tumors and represent a rare occurrence, accounting for less than 1% of all adult intracranial tumors. Among these, primary pineal malignant melanomas (PPM) represent an even rarer entity, with only twenty-five cases being reported in the literature to date. We present the case of a 65-year-old patient who presented in our department for progressive headache, gait disturbance and memory impairment. Magnetic resonance imaging (MRI) of the brain revealed a solid mass in pineal region, measuring 2.2 × 1.2 × 2.0 cm and causing obstructive hydrocephalus. He underwent a third ventriculostomy, but we failed to obtain a sample for diagnostic purposes. The intraoperative surprise was the presence, at the level of the third ventricle, of multiple melanin deposits, which were not picked up by the MRI. Although the biopsy could not be performed and had to be obtained by stereotactic biopsy in a second intervention, the endoscopy findings allowed for the correct staging of the intracranial disease and appropriate treatment management. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>Preoperative images (<b>A</b>) nonenhanced computer tomography showing hyperdense mass at the level of pineal gland. The lesions are hyperintense in T1 (<b>B</b>,<b>C</b>), hypointense in T2 (<b>D</b>), and exhibit marked reduced diffusion on DWI (<b>E</b>). The lesion is compressing the tectal plate, obstructing the cerebral aqueduct and determining active hydrocephalus (arrows) (<b>F</b>).</p>
Full article ">Figure 2
<p>Intraoperative images, (<b>A</b>) anterior portion of the 3rd ventricle floor showing the mammillary bodies (star), and tuber cinereum through which posterior cerebral arteries (arrows) can be observed, along with tumoral dissemination at the level of the pituitary infundibulum and tuber cinereum (arrow heads). (<b>B</b>) Intraoperative aspect showing the stoma (arrow) and other disseminations at the level of the optic chiasm and lamina terminalis (arrow heads). (<b>C</b>) Endoscopic view of the posterior 3rd ventricle showing the black lesion and the involvement of the tegmentum.</p>
Full article ">Figure 3
<p>Pathological examination. (<b>A</b>) Nervous tissue with a relatively normal appearance (black arrow). Its subpial side is infiltrated by small groups of tumor cells loaded cytoplasmically with a brown granular pigment (melanin) (blue arrows), and on the opposite side its structure is replaced by a densely cellularized tumor, made up of atypical cell sheets with cytoplasm loaded with abundant granular brown pigment resembling melanin (yellow arrows) (HE, ×20). (<b>B</b>) Sheets of voluminous tumor cells, with a fusiform appearance, arranged in thick fascicles that intertwine in different directions. Tumor cells show nuclear pleomorphism and an abundant granular brown pigment resembling melanin in their cytoplasm (HE, ×200). (<b>C</b>) S100 staining, ×200. (<b>D</b>) Mart1 staining, ×200.</p>
Full article ">Figure 4
<p>MRI images showing the evolution of the lesion from the diagnosis (<b>A</b>) and after radiation therapy at 4 months (<b>B</b>) and 12 months (<b>C</b>), showing moderate progression and (<b>D</b>) MRI at 16 months, showing important growth of the lesion and leptomeningeal spreading with multiple intracranial metastases (arrows).</p>
Full article ">
Back to TopTop